1. Home
  2. |Insights
  3. |Expedited Contract Closeouts – A Fast Track Available to Select Older Contracts

Expedited Contract Closeouts – A Fast Track Available to Select Older Contracts

Client Alert | 1 min read | 05.28.19

On April 30, 2019, the Department of Defense (DoD) issued a final rule, effective immediately, amending the Defense Federal Acquisition Regulation Supplement (DFARS) to permit expedited closeout of certain contracts (or groups of contracts) through modification of such contracts without completing a reconciliation audit or other corrective action. The new provision—which implements section 836 of the National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2017 and section 824 of the NDAA for FY 2018—applies when: (1) the contract was entered into on a date that is at least 17 fiscal years before the current fiscal year; (2) there are no further supplies or services due under the contract; and (3) a determination has been made that the contract records are not otherwise reconcilable because either (a) the contract or related payments records have been destroyed or lost, or (b) the time and effort required to establish the exact amount owed is disproportionate to the amount at issue. To accomplish closeout of such contracts, the final rule permits negotiated settlements with the contractor and remaining contract balances to be offset with balances within the contract or on other contracts irrespective of the year, the type of appropriation obligated to fund each contract or contract line item, and regardless of whether the appropriation has closed.

Insights

Client Alert | 15 min read | 08.20.25

The New EU “Pharma Package”: Interplay with the Critical Medicines Act and other shortage initiatives

In this eighth alert in our weekly series on the EU Pharma Package, we continue our overview of initiatives with respect to security of supply and shortage prevention and mitigation. Our last alert looked at how the Pharma Package seeks to address these issues. However, the Pharma Package does not exist in isolation, and in this alert we will discuss the interplay between its measures and those contained in other important EU initiatives such as the proposed Critical Medicines Act (CMA), and the Medicinal Countermeasures Strategy and the EU Stockpiling Strategy....